| Whole sample (n = 1163) | APO (n = 563) | Controls (n = 600) | P value |
---|---|---|---|---|
Hcy (μmol/L) | 7.98 (7.03–12.60) | 8.43 (7.16–14.27) | 7.79 (6.90–8.34) | < 0.001 |
Folate (nmol/L) | 21.43 (18.31–29.25) | 20.26 (17.04–27.24) | 23.80 (19.48–30.24) | < 0.001 |
VB12 (pmol/L) | 401.28 (255.81–546.90) | 377.68 (233.03–541.13) | 414.63 (269.85–548.17) | 0.002 |
hs-CRP (mg/L) | 3.74 (1.68–9.21) | 4.15 (1.56–9.57) | 3.59 (1.68–8.49) | 0.149 |
IL-6 (pg/mL) | 37.28 (23.64–74.57) | 37.87 (24.29–74.57) | 36.80 (22.95–73.23) | 0.143 |
TC (mmol/L) | 5.34 ± 1.20 | 5.46 ± 1.31 | 5.23 ± 1.08 | 0.001 |
TG (mmol/L) | 1.92 ± 1.05 | 1.97 ± 1.10 | 1.87 ± 1.01 | 0.010 |
LDL-C (mmol/L) | 3.08 ± 1.01 | 3.19 ± 1.09 | 2.97 ± 0.91 | < 0.001 |
HDL-C (mmol/L) | 1.38 ± 0.35 | 1.33 ± 0.39 | 1.43 ± 0.31 | < 0.001 |
FPG (mmol/L) | 4.79 ± 1.36 | 4.91 ± 1.57 | 4.67 ± 1.13 | 0.003 |
UA (μmol/L) | 318.31 ± 58.50 | 318.97 ± 59.15 | 317.69 ± 57.92 | 0.708 |
Age (years) | 28.86 ± 5.25 | 29.69 ± 5.94 | 28.02 ± 4.38 | < 0.001 |
SBP (mmHg) | 127.99 ± 16.20 | 129.68 ± 17.46 | 126.39 ± 14.77 | < 0.001 |
DBP (mmHg) | 82.08 ± 8.11 | 83.19 ± 8.92 | 81.04 ± 7.12 | < 0.001 |
BMI (kg/m2) | 21.82 ± 3.12 | 22.23 ± 3.12 | 21.44 ± 3.08 | < 0.001 |
Age over 35y (%) | 15.05 | 19.54 | 10.83 | < 0.001 |
Folate supplementation (%) | 88.22 | 82.77 | 93.33 | < 0.001 |
VB12 supplementation (%) | 82.55 | 80.11 | 84.83 | 0.034 |
Smoking (%) | 2.06 | 2.49 | 1.67 | 0.326 |
Excessive drinking (%) | 3.96 | 3.73 | 4.17 | 0.703 |
Hypercholesterolemia (%) | 15.56 | 20.25 | 11.17 | < 0.001 |
Hypertriglyceridemia (%) | 20.46 | 22.56 | 18.50 | 0.087 |
Low HDL-C (%) | 13.50 | 18.65 | 8.67 | < 0.001 |
High LDL-C (%) | 19.00 | 25.04 | 13.33 | < 0.001 |
Gestational diabetes (%) | 8.34 | 10.30 | 6.50 | 0.019 |
Hypertension (%) | 11.26 | 14.21 | 8.50 | 0.002 |
Underweight (%) | 5.16 | 4.80 | 5.50 | 0.587 |
Overweight and obesity (%) | 18.40 | 21.31 | 15.67 | 0.013 |